• No se han encontrado resultados

C. La razón para tan grande castigo

III. LA CAÍDA

This study was intended to contribute to the knowledge base of the anticancer therapeutic potential of Asparagus laricinus, Senecio asperulus and Gunnera perpensa. It should be noted that plant material used in this study were chosen based on the ethnobotanical claims made by cancer-treating traditional healers in Lesotho as well as supported by recorded ethnobotanical studies. Asparagus laricinus was reported to be used for prostate cancer patients in Limpopo province in South Africa, Senecio asperulus was reported to be used for cancer treatment in Lesotho and Gunnera perpensa was reported to be used for cancer treatment in Lesotho and in the Eastern Cape province in South Africa. Moreover, a mixture of Senecio asperulus and Gunnera perpensa aqueous extracts have been avowed by a traditional herbalist in Lesotho as an effective concoction for the treatment of breast and prostate cancer.

Since other compounds are extracted better with different solvents because of the

differences in polarity, extraction using a variety of solvents was performed to demonstrate a vast difference in their pharmacological activities as far as the experimental results are concerned. However, to account for possible geographical and chemotypic variations, plant material should be studied from several populations in comparison with each other; for example, effects of Asparagus laricinus Burch from Lesotho and South Africa, in the future. Based on the results observed from this study, the recommendations below were made:

i. The activity-guided fractionation, isolation, and identification of identified compounds are imperative, as these may lead to the development of novel treatments in the global struggle against cancer and cancer-related ailments.

ii. No single testing method can provide a comprehensive profile of the antioxidant and anti-inflammation capacity of a plant species, because of the complexity of oxidation-anti-oxidation and inflammation-induction processes. Therefore, different methods are to be used to determine the antioxidant potential and the regulation of other inflammation-related enzymes such as COX-2.

iii. It is recommended that a thorough geographical variation study be performed on each species to explain the chemical diversity between individuals within a population and between populations.

iv. Isolation and structural elucidation of unknown compounds should be studied further so that they can be named.

v. The study on the isolation and identification of the detected unknown compounds can be conducted, but now with the pure and targeted compounds using the guidance of compounds identified under phytochemical screening analysis.

vi. Isolated compounds to be tested on breast (MCF-7) cells again to determine if the activity of tested extracts with anticancer activities was due to a specific compound or several compounds working in synergy.

vii. Toxicity of each isolated compound should then be investigated.

viii. In vivo pharmacological investigation (targeting diseases that these plants have been traditionally used for) of active isolated compounds and crude extracts (as the activity might be synergical from all compounds in each plant).

ix. In vivo anticancer activity investigation of Asparagus laricinus, Senecio asperulus and Gunnera perpensa as some compounds behave differently in vivo when compared to in vitro.

x. Investigation of a mixture of Senecio asperulus and Gunnera perpensa as anticancer drugs for prostate and breast cancer as their activity might be due to synergistic effect when compounds from both plants extracts act together simultaneously.

xi. In vivo anticancer activity of the Senecio asperulus and Gunnera perpensa mixture as claimed by the traditional herbalist in Lesotho, using a mixture of both plants be investigated.

8.7 REFERENCES

Brookes K.B, Dutton M.F. 2007. “Bioactive Components of the Uteroactive Medicinal Plant, Gunnera Perpensa (or Ugobo): Research in Action.” South African Journal of Science. 103(5 & 6):187–189.

Chambers H.F, DeLeo F.R. 2009. Waves of Resistance: Staphylococcus aureus in the Antibiotic Era. Nat Rev Microbiol. 7(9):629–641.

Clinical and Laboratory Standards Institute (CLSI). 2009. Performance standards for antimicrobial disk susceptibility tests; approved standard-tenth edition M02-A10.

National Committee for Clinical Laboratory Standards 29.

Cragg G.M, Newman D.J. 2000. Antineoplastic agents from natural sources:

Achievements and future directions. Expert Opinion on Investigational Drugs. 9:1-15.

De Nunzio C, Kramer C, Marberger M, Montironi R, Nelson W, Schröder F, SciarraA, Tubaro A. 2011. The controversial relationship between benign prostatic hyperplasia and prostate cancer: The role of inflammation. European Urology. 60:106-117.

Deciga-Campos M, Rivero-Cruz I, Arriaga-Alba M, Castaneda-Corral G, Angeles-Lopez G.E, Navarrete A, Mata R. 2007. Acute toxicity and mutagenic activity of Mexican plants used in traditional medicine. Journal of Ethnopharmacology. 110:334-342.

Decker E.A. 1995. The role of phenolics, conjugated linoleic acid, carnosine and pyrrolquinolinequinone as nonessential dietary antioxidants. Nutrition Reviews. 53:49.

Fang YZ. 1991. Effect of ionizing radiation on superoxide dismutase in vitro and in vivo. In: Fang YZ (English edition). Advances in Free Radical Biology and Medicine.

Vol 1:1. Beijing: Atomic Energy Press.

Fang YZ. 2002. Free radicals and nutrition. In: Fang YZ, Zheng RL (eds.) Theory and Application of Free Radical Biology. Beijing: Scientific Press. p. 647.

Fang Y, De Marco V.G, Nicholl MB. 2012. Resveratrol enhances radiation sensitivity in prostate cancer by inhibiting cell proliferation and promoting cell senescence and apoptosis. Cancer Science. 103:1090-1098.

Ferrari C.K.B, Torres E.A.F.S. 2003. Biochemical pharmacology of functional foods and prevention of chronic diseases of aging. Biomedicine & Pharmacotherapy.

57:251-260.

Hertog M.G.L, Hollman P.C.H, Van de Putte B. 1993. Content of potentially anticarcinogenic flavonoids of tea infusions, wines, and fruit juices. Journal of Agricultural and Food Chemistry. 41:1242-1246.

Kang J. 2012. Principles and Applications of LC-MS/MS for the Quantitative Bioanalysis of Analytes inVarious Biological Samples, Tandem Mass Spectrometry - Applications and Principles. Dr. Jeevan Prasain (Ed.), ISBN: 978-953-51-0141-3, InTech. pp. 441-492.

Kaskiw M.J, Tassotto M.L, Mok M, Tokar S.L, Pycko R, Th'ng J, Jiang Z.H. 2009.

Structural analogues of diosgenyl saponins: Synthesis and anticancer activity.

Bioorganic & Medicinal Chemistry. 17(22):7670-9.

Kinghorn A.D, Farnsworth N.R, Soejarto D.D, Cordell G.A, Swanson S.M, Pezzuto J.M, Wani M.C, Wall M.E, Kroll N.H, Kramer R.A, Rose W.C, Vite G.D, Fiarchild C.R, Peterson R.W, Wild R. 2003. Novel strategies for the discovery of plant-derived anticancer agents. Pharmaceutical Biology. 41:53–67.

Michielin E.M.Z, Salvador A.A, Riehl C.A.S, Smania A, Smania E.F.A, Ferreira S.R.S.

2009. Chemical composition and antibacterial activity of Cordia verbenacea extracts obtained by different methods. Bioresource Technology. 100:6615-6623.

Moreno S, Scheyer T, Romano C.S, Vojnov A.A. 2006. Antioxidant and antimicrobial activities of rosemary extracts linked to their polyphenol composition. Free Radic. Res.

40:223–231.

Niki E, Shimaski H, Mino M. 1994. Antioxidant-free and biological defense. Gakkai Syuppn Center, Tokyo. p. 3-16.

Ngo T.V, Scarlett C.J, Bowyer M.C, Ngo P.D, Vuong Q.V. 2017. Impact of Different Extraction Solvents on Bioactive Compounds and Antioxidant Capacity from the Root of Salacia chinensis L. Journal of Food Quality. Article ID 9305047, 8 pages https://doi.org/10.1155/2017/9305047.

Pantosti A, Sanchini A, Monaco M. 2007. Mechanisms of antibiotic resistance in Staphylococcus aureus. Future Microbiol. 2(3):323-34.

Raafat D, Sahl, H.G. 2009. Chitosan and its antimicrobial potential – a critical literature survey. Microbial Biotechnology. 2:186-201.

Reddy L, Odhav B, Bhoola K.D. 2003. Natural products for cancer prevention: A global perspective. Pharmacology and therapeutics. 99:1-13.

Rice-Evans C.A, Miller N.J, Paganga G. 1996. Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Rad. Biol. Med. 20(7):933.

Sakai Y, Nagase H, Ose Y, Sato T, Kawai M, Mizuno M. 1988. Effects of medicinal plant extracts from Chinese herbal medicines on the mutagenic activity of benzo[a]pyrene. Mutation Research/Genetic Toxicology. 206(3):327-334.

Seyoum A, Asres K, El-Fiky F.K. 2006. Structure-radical scavenging activity relationships of flavonoids. Phytochemistry. 67:2058-2070.

Ward J.L, Harris C, Lewis J, Beale M.H. 2003. Assessment of 1H NMR spectroscopy an multivariate analysis as a technique for metabolite fingerprinting of Arabidopsis thaliana. Phytochemistry. 62:949 - 957.

Wolfender J.L, Ndjoko K, Hostettmann K. 2003. Liquid chromatography with ultraviolet absorbance-mass spectrometric detection and with nuclear magnetic resonance

spectroscopy: a powerful combination for the on-line structural investigation of plant metabolites. Journal of Chromatography A. 1000:437-455.

Yan L.L, Zhang Y.J, Gao W.Y, Man S.L, Wang Y. 2009. In vitro and in vivo anticancer activity of steroid saponins of Paris polyphylla var. yunnanensis. Experimental Oncology. 31(1):27-32.

Yen G, Wu S, Duh P. 1996. Extraction and identification of antioxidant components from the leaves of mulberry (Morus alba L.). Journal of Agricultural and Food Chemistry. 44:1687–90.

APPENDIX

(A) PLANT COLLECTION PERMIT (from South Africa)

(B) PLANT COLLECTION PERMIT (from Lesotho)

Documento similar